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INTRODUCTION
History has often predicted the direction of human
activity. Science may be ranked as the human activity
that has led to the most beneficial outcomes in all
generations. Science is a system of  organizing the
knowledge about a particular subject; such knowledge
as has been obtained by unbiased observation or
experimentation in a reproducible and provable
manner.
The sciences are classifiable into basic and applied. The
basic sciences of physics, mathematics and chemistry
often interact with the biological sciences.
Advancements in biology are limited by precision of
observation and variability of  biological activities. The
interphase between biology and the physical sciences
accelerate developments in biological sciences. The
impact of physical sciences in the subspecialty
Radiology is undeniable. Human Medicine, an applied
science with diverse sub-branches, is unarguably a very
important stem of  the biological sciences.
Bioengineering, biotechnology, biophysics,
biochemistry are a few of the disciplines that have
resulted from interphases of physical and biological
sciences.
The discovery of the structure of the DNA and
eventually the illumination of the genetic code were
outcomes of  physical and biological interphases. This
write up examines a potentially more significant
discipline, Biomimetics. Biomimetics literally means
imitations of life. The scope and the potential impact
in human biology and medicine will be discussed and
this historical review, based on the early publications
on the subject as cited on PUBMED, will be a pointer
to the future prospects of this new and emerging
discipline.
History of  Biomimetics
Historically, mankind has imitated models and elements
of nature for the purpose of solving complex
problems. The anatomy and flight of  birds contributed
to the discovery of human flying machines (aircrafts).
Leonardo da Vinci (1425 – 1519) made numerous
diagrams of flying machines from his close studies of
bird flight. The Wright brothers who succeeded in
devising aircrafts derived their ideas from observing
birds, Otto Schmitt, an American physicist coined the
term Biomimetics. His focus on devices that mimic
natural systems led to the birth of the field of
biophysics, and more recently, biomimetics.
Otto Herbert Schmitt (06 April, 1913 – 06 January,
1998)
Otto Herbert Schmitt was born at Missouri, USA. He
attended Washington University, University of
Minnesota, and University College, London. He was
the third child of  his parents. His extraordinary talent
for invention started to show during his high school.
His skill in the use of electrical instruments was
developed very early in his educational journey. From
high school he proceeded to the University of
Washington on Sept 18, 1930 where he displayed
unparallel skill in mathematics physics, and electronics.
His graduate work was on the molecular organization
of  cells and tissues with special focus on nerve fibers.
He utilized his prowess for electrical engineering to
create artificial constructs that were able to mimic the
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formation and propagation of  impulses along nerve
fibers.
He earned his Ph.D with majors in physics and zoology.
Within a short time after this he earned the National
Research Fellowship of  the United Kingdom which
enabled him to do research on nerve impulses under
Professor A.V. Hill, Nobel Prize winner and founder
of  biophysics at Woods Hole. It was during that time
that Schmitt published a report on a novel bit of
of  antileukemic triptolides.1’ The reaction they
described mimics the inhibition of tumor growth via
selective alkylation of the thiol groups of key enzymes
concerned with growth regulation. In 1978 Giannetti
and others searched for new antibiotics from
substances isolated from fruiting bodies of tremellous
and phlebia radiata.2 In 1979, Stevens MF and colleagues
studied ‘antitumor activities of biomimetic oxidation
and metabolism of  heterocyclic triazenes.3’ In 1980
Le Quesne PW and his colleagues wrote on the
‘Biomimetic synthesis of  cathecol estrogens.4’ In 1983,
Dimmock JR and colleagues evaluated compounds
that showed reactivity towards a biomimetic thiol.5
Finally, in 1983 kensler TW with two co-authors
publish a report on ‘inhibition of tumor promotion
by a biomimetic superoxide dismutase.6’ Their study
suggested that reactive oxygen species played significant
roles in the tumor promotion process. This paper
ended the first set of clinically related biomimetic
papers (the first ten years). These papers were mainly
motivated by objectives of uncovering the secrets that
may lead to cures for cancers.
The next ten years (1983 – 1994) returned 36
publications on the theme of biomimetics, an 85%
increase. It was clear by that time that more and more
researchers saw the young field as a very promising
approach to discovery of underlying principles of
biology. From cancer-related objectives, biomimetics
research has rapidly grown to include other areas of
medical investigation. The majority of the papers in
this next era were on cancer-related biomimetics
research, however, the other areas that were investigated
included antibiotics, biosensor applications, ligand-
receptor studies, metabolism, anti-parasitic agents
(including evaluation of materials for anti-malarial
activities), polymer chemistry (which led to nano-
substances), analytic chemistry, neurobiology, and
medical imaging.7-40 The growth of  biomimetics has
continued in an exponential rate with virtually every
aspect of  biology included. Perhaps the most
fascinating aspect of biomimetics is biosensor research.
A biosensor is an analytical device, used for the
detection of an analyte that combines a biological
component with a physicochemical detector. The
sensitive biological element could be any biological
component e.g. a cell, tissue, organelle, cell receptor,
enzyme, antibody, nucleic acid, etc. Biosensors utilize
biomimetic processes to detect the analyte, generate
amplifiable signals, which are further processed by a
transducer (the physicochemical component). The
physicochemical processes may be optical, electrical,
electrochemical, etc. the resulting signals are amplified
and recorded as quantifiable impulses in user-friendly
 Otto Herbert Schmitt
circuitry that won him fame. Prof Hill, recognizing
Otto’s talent, sought out additional sources of  funding
to keep Otto in London for as long as he could.
Schmitt eventually had to return to the United States.
He got a Faculty position at the University of Minnesota
with a dual appointment to the departments of
zoology and physics. University of  Minnesota gave
Otto incentives to keep him which included “Tenure
as an associate professor (skipping the rank of assistant
professor), a 28% pay rise, triple research funding, and
guaranteed support for two graduate students.” Otto
had a natural flair for innovation and inventions. His
work led to the formation of  biophysics, biomedical
engineering, and ultimately biomimetics. Biomimetics
has grown as one of the largest areas of biomedical
engineering, and this new discipline is rapidly
expanding.
The Early Years of  Biomimetics (1974 – 1994)
The early years of biomimtics as relevant to human
medicine and clinical research could be seen by a
PUBMED search of Biomimetics and Clinical
Research. The search (done by this author on 22
December 2014) indicated that the early years of
Biomimetics span from 1974 to 1994, a period of
twenty years. Forty publications with the theme of
biomimetics were published and listed on PUBMED.
In 1974 Kupchan SM and Schubert RM published a
paper titled ‘selective alkylation: a biomimetic reaction
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interphases. Automated biosensor systems have almost
limitless applications.
Applications of biosensor systems are very diverse and
universal, especially in biological disciplines. These
include glucose monitoring, receptor-ligand
interactions, metabolites detectors, all modalities of
imaging, trace gas/element detectors, electronic
thermometers, digital meters, microarrays, nanoscale
biosensors, etc. The future of biomimetics research
and applications will significantly be in the direction
of  biosensors as diagnostics and therapeutics.
CONCLUSIONS
Disease continues to plague mankind at unprecedented
levels. Biomimetics research offers an innovative and
different approach to our onslaught of pathogenic
processes. For the first time in our history of  science a
discipline that sees the way nature sees has been born.
It is obvious that biomimetics research has the potentials
for transforming the way medicine is practiced. The
results are as exciting as they are intriguing. We have
started scratching at the surface of what nature has
perfected over billions of  years. It is by mimicking
nature that her immutable laws can be uncovered in
their purest forms. Is biomimetics man’s tool for the
ultimate conquest of sickness and disease? Only time
will tell.
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